Definitive Healthcare (NASDAQ:DH) Shares Down 4.9% - Here's What Happened

Definitive Healthcare Corp. (NASDAQ:DH - Get Free Report) shares traded down 4.9% on Wednesday . The stock traded as low as $4.76 and last traded at $4.77. 104,155 shares traded hands during trading, a decline of 86% from the average session volume of 756,992 shares. The stock had previously closed at $5.01.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on DH. Barclays restated an "underweight" rating and set a $4.00 price objective on shares of Definitive Healthcare in a research report on Monday, January 13th. Stephens began coverage on shares of Definitive Healthcare in a research note on Friday, December 20th. They issued an "equal weight" rating and a $5.00 price target on the stock. Finally, Needham & Company LLC reissued a "hold" rating on shares of Definitive Healthcare in a report on Thursday, January 16th. Two investment analysts have rated the stock with a sell rating, six have issued a hold rating and three have issued a buy rating to the stock. According to MarketBeat, the company has an average rating of "Hold" and a consensus target price of $5.72.

Definitive Healthcare Stock Performance

The company has a market capitalization of $568.94 million, a PE ratio of -1.59, a P/E/G ratio of 3.54 and a beta of 1.41. The stock's 50-day simple moving average is $4.38 and its 200 day simple moving average is $4.45. The company has a debt-to-equity ratio of 0.33, a quick ratio of 2.49 and a current ratio of 2.49.

Definitive Healthcare (NASDAQ:DH - Get Free Report) last announced its quarterly earnings results on Thursday, November 7th. The company reported $0.05 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.08 by ($0.03). Definitive Healthcare had a negative net margin of 142.38% and a positive return on equity of 1.76%. The business had revenue of $62.70 million during the quarter, compared to analyst estimates of $61.66 million. During the same period last year, the company earned $0.01 earnings per share. As a group, research analysts expect that Definitive Healthcare Corp. will post 0.15 earnings per share for the current fiscal year.

Insider Buying and Selling at Definitive Healthcare

In other Definitive Healthcare news, insider William Moschella sold 45,000 shares of the company's stock in a transaction dated Tuesday, December 3rd. The shares were sold at an average price of $4.70, for a total transaction of $211,500.00. Following the transaction, the insider now directly owns 433,830 shares in the company, valued at approximately $2,039,001. This represents a 9.40 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. 14.84% of the stock is currently owned by company insiders.

Institutional Trading of Definitive Healthcare

Institutional investors and hedge funds have recently modified their holdings of the business. Nisa Investment Advisors LLC lifted its stake in shares of Definitive Healthcare by 3,652.7% during the fourth quarter. Nisa Investment Advisors LLC now owns 6,980 shares of the company's stock valued at $29,000 after buying an additional 6,794 shares during the period. Point72 DIFC Ltd increased its position in Definitive Healthcare by 759.9% during the third quarter. Point72 DIFC Ltd now owns 9,296 shares of the company's stock worth $42,000 after purchasing an additional 8,215 shares during the last quarter. Intech Investment Management LLC acquired a new position in Definitive Healthcare during the third quarter worth approximately $55,000. Bleakley Financial Group LLC acquired a new position in Definitive Healthcare during the third quarter worth approximately $74,000. Finally, Glenmede Trust Co. NA increased its position in Definitive Healthcare by 41.1% during the third quarter. Glenmede Trust Co. NA now owns 18,423 shares of the company's stock worth $82,000 after purchasing an additional 5,362 shares during the last quarter. Hedge funds and other institutional investors own 98.67% of the company's stock.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.